These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2108456)

  • 1. HIV seroprevalence surveys in drug treatment centers.
    Jones TS; Allen DM; Onorato IM; Petersen LR; Dondero TJ; Pappaioanou M
    Public Health Rep; 1990; 105(2):125-30. PubMed ID: 2108456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV seroprevalence surveys in sexually transmitted disease clinics.
    Onorato IM; McCray E; Pappaioanou M; Johnson R; Aral S; Hardy AM; Dondero TJ
    Public Health Rep; 1990; 105(2):119-24. PubMed ID: 2108455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining HIV seroprevalence among women in women's health clinics.
    Allen DM; Lee NC; Schulz SL; Pappaioanou M; Dondero TJ; Onorato IM
    Public Health Rep; 1990; 105(2):130-4. PubMed ID: 2108457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating HIV levels and trends among patients of tuberculosis clinics.
    McCray E; Onorato IM; Miller BI; Dondero TJ; Bloch AB
    Public Health Rep; 1990; 105(2):135-40. PubMed ID: 2108458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States.
    Pappaioanou M; Dondero TJ; Petersen LR; Onorato IM; Sanchez CD; Curran JW
    Public Health Rep; 1990; 105(2):113-9. PubMed ID: 2157233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
    Lima ES; Bastos FI; Telles PR; Friedman SR
    Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992. Field Services Branch.
    Lehman JS; Allen DM; Green TA; Onorato IM
    AIDS; 1994 Oct; 8(10):1465-9. PubMed ID: 7818818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods of surveillance for HIV infection at U.S. sentinel hospitals.
    St Louis ME; Olivo N; Critchley S; Rauch KJ; White CR; Munn VP; Dondero TJ
    Public Health Rep; 1990; 105(2):140-6. PubMed ID: 2108459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel surveillance of HIV infection among new inmates and implications for policies of corrections facilities.
    Patel KK; Hutchinson C; Sienko DG
    Public Health Rep; 1990; 105(5):510-4. PubMed ID: 2120729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of data from the CDC Family of Surveys.
    Onorato IM; Gwinn M; Dondero TJ
    Public Health Rep; 1994; 109(2):204-11. PubMed ID: 8153271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992.
    Weinstock HS; Sidhu J; Gwinn M; Karon J; Petersen LR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):514-22. PubMed ID: 7627627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of drug abuse treatment for primary prevention of acquired immunodeficiency syndrome: epidemiologic considerations.
    Lampinen TM
    NIDA Res Monogr; 1991; 113():114-28. PubMed ID: 1762635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using seroprevalence data in managing public health programs.
    Onorato IM; Jones TS; Forrester WR
    Public Health Rep; 1990; 105(2):163-6. PubMed ID: 2108463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Condom use and HIV risk behaviors among U.S. adults: data from a national survey.
    Anderson JE; Wilson R; Doll L; Jones TS; Barker P
    Fam Plann Perspect; 1999; 31(1):24-8. PubMed ID: 10029929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV seroprevalence surveys of childbearing women--objectives, methods, and uses of the data.
    Pappaioanou M; George JR; Hannon WH; Gwinn M; Dondero TJ; Grady GF; Hoff R; Willoughby AD; Wright A; Novello AC
    Public Health Rep; 1990; 105(2):147-52. PubMed ID: 2108460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the levels and trends of HIV infection: the Public Health Service's HIV surveillance program.
    Dondero TJ; Pappaioanou M; Curran JW
    Public Health Rep; 1988; 103(3):213-20. PubMed ID: 3131809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.
    Battjes RJ; Pickens RW; Brown LS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):90-6. PubMed ID: 7648291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.